Chlorambucil in Behcet's disease. A reappraisal

K. F. Tabbara

Research output: Contribution to journalArticle

Abstract

Ten patients with Behcet's disease were treated with chlorambucil alone. At the therapeutic drug level of 0.2 mg/kg, seven patients developed oligospermia and three patients developed azoospermia. A 30-year-old patient underwent a testicular biopsy two years after the cessation of therapy. Histopathology revealed evidence of testicular atrophy. Fifteen (75%) out of 20 eyes had a visual acuity of 20/200 or less following therapy. It is concluded that chlorambucil should not be used as the first line of therapy in Behcet's disease and that its long term benefits in patients with Behcet's disease should be reevaluated.

Original languageEnglish (US)
Pages (from-to)906-908
Number of pages3
JournalOphthalmology
Volume90
Issue number8
StatePublished - 1983
Externally publishedYes

Fingerprint

Chlorambucil
Behcet Syndrome
Oligospermia
Azoospermia
Therapeutics
Visual Acuity
Atrophy
Biopsy
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Tabbara, K. F. (1983). Chlorambucil in Behcet's disease. A reappraisal. Ophthalmology, 90(8), 906-908.

Chlorambucil in Behcet's disease. A reappraisal. / Tabbara, K. F.

In: Ophthalmology, Vol. 90, No. 8, 1983, p. 906-908.

Research output: Contribution to journalArticle

Tabbara, KF 1983, 'Chlorambucil in Behcet's disease. A reappraisal', Ophthalmology, vol. 90, no. 8, pp. 906-908.
Tabbara, K. F. / Chlorambucil in Behcet's disease. A reappraisal. In: Ophthalmology. 1983 ; Vol. 90, No. 8. pp. 906-908.
@article{83695847887e4c5199c6ac9867366bf2,
title = "Chlorambucil in Behcet's disease. A reappraisal",
abstract = "Ten patients with Behcet's disease were treated with chlorambucil alone. At the therapeutic drug level of 0.2 mg/kg, seven patients developed oligospermia and three patients developed azoospermia. A 30-year-old patient underwent a testicular biopsy two years after the cessation of therapy. Histopathology revealed evidence of testicular atrophy. Fifteen (75{\%}) out of 20 eyes had a visual acuity of 20/200 or less following therapy. It is concluded that chlorambucil should not be used as the first line of therapy in Behcet's disease and that its long term benefits in patients with Behcet's disease should be reevaluated.",
author = "Tabbara, {K. F.}",
year = "1983",
language = "English (US)",
volume = "90",
pages = "906--908",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Chlorambucil in Behcet's disease. A reappraisal

AU - Tabbara, K. F.

PY - 1983

Y1 - 1983

N2 - Ten patients with Behcet's disease were treated with chlorambucil alone. At the therapeutic drug level of 0.2 mg/kg, seven patients developed oligospermia and three patients developed azoospermia. A 30-year-old patient underwent a testicular biopsy two years after the cessation of therapy. Histopathology revealed evidence of testicular atrophy. Fifteen (75%) out of 20 eyes had a visual acuity of 20/200 or less following therapy. It is concluded that chlorambucil should not be used as the first line of therapy in Behcet's disease and that its long term benefits in patients with Behcet's disease should be reevaluated.

AB - Ten patients with Behcet's disease were treated with chlorambucil alone. At the therapeutic drug level of 0.2 mg/kg, seven patients developed oligospermia and three patients developed azoospermia. A 30-year-old patient underwent a testicular biopsy two years after the cessation of therapy. Histopathology revealed evidence of testicular atrophy. Fifteen (75%) out of 20 eyes had a visual acuity of 20/200 or less following therapy. It is concluded that chlorambucil should not be used as the first line of therapy in Behcet's disease and that its long term benefits in patients with Behcet's disease should be reevaluated.

UR - http://www.scopus.com/inward/record.url?scp=0020643888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020643888&partnerID=8YFLogxK

M3 - Article

C2 - 6634072

AN - SCOPUS:0020643888

VL - 90

SP - 906

EP - 908

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 8

ER -